Prestige Consumer Healthcare Inc. (PBH) is a publicly traded Healthcare sector company. As of May 21, 2026, PBH trades at $46.40 with a market cap of $2.21B and a P/E ratio of 12.04. PBH moved +1.96% today. Year to date, PBH is -24.46%; over the trailing twelve months it is -46.11%. Its 52-week range spans $42.62 to $90.04. Analyst consensus is strong buy with an average price target of $82.89. Rallies surfaces PBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading PBH stock inside the company?
Recent PBH insider activity includes Zerillo Jeffrey sold 351, Zerillo Jeffrey sold 305, Zerillo Jeffrey sold 1.21K, Zerillo Jeffrey sold 346, and Zerillo Jeffrey sold 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
PBH Key Metrics
Key financial metrics for PBH
Metric
Value
Price
$46.40
Market Cap
$2.21B
P/E Ratio
12.04
EPS
$3.93
Dividend Yield
0.31%
52-Week High
$90.04
52-Week Low
$42.62
Volume
120
Avg Volume
0
Revenue (TTM)
$1.09B
Net Income
$190.30M
Gross Margin
54.70%
Recent PBH Insider Trades
Zerillo Jeffrey sold 351 (~$18.35K) on May 11, 2026.
Zerillo Jeffrey sold 305 (~$16.58K) on May 7, 2026.
Zerillo Jeffrey sold 1.21K (~$66.37K) on May 5, 2026.
Zerillo Jeffrey sold 346 (~$19.14K) on May 5, 2026.
Zerillo Jeffrey sold 1.00K (~$65.93K) on Feb 11, 2026.
Recent PBH insider activity includes Zerillo Jeffrey sold 351, Zerillo Jeffrey sold 305, Zerillo Jeffrey sold 1.21K, Zerillo Jeffrey sold 346, and Zerillo Jeffrey sold 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PBH?
Yes. Rallies tracks PBH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PBH. It does not provide personalized investment advice.
